Close

Professor Helen Stagg

Professor of Infectious Disease Epidemiology

United Kingdom

I initially trained at the University of Cambridge in the life sciences (cell biology, immunology, virology; PhD) and later at the London School of Hygiene & Tropical Medicine (epidemiology, MSc). I have worked with industry, and national and international policy making/influencing bodies (particularly the Scottish Parliament, National Institute for Health and Care Excellence UK, European Centre for Disease Prevention and Control, and the World Health Organization). I have previously held a European Respiratory Society International Short-Term Research Training Fellowship, National Institute for Health Research Postdoctoral Fellowship, a Chancellor’s Fellowship (tenure-track) at the University of Edinburgh, and a Medical Research Council Career Development Award. I have honorary contracts at University College London and the University of Edinburgh.

I am a member of the World Health Organization's core grouping for the European Tuberculosis Research Initiative, a Fellow of the Young Academy of Europe, and was the co-chair of UK Academics and Professionals to End Tuberculosis with Prof. Bertie Squire 2020-2022.

Affiliations

Department of Infectious Disease Epidemiology and International Health
Faculty of Epidemiology and Population Health

Centres

TB Centre

Teaching

I hold an Advance HE Fellowship and am the co-module organiser for Statistical Methods in Epidemiology. I co-run a yearly workshop on sex/gender and race/ethnicity in statistical models for LSHTM masters' students.

Research

My group has four main programmes of currently ongoing research work:

treatment adherence in chronic conditions
treatment optimisation in tuberculosis
antimicrobial resistance
herpesviruses

Research Area
Epidemiology
Population health
Systematic reviews
Bacteria
Drug resistance
Global health
Complex interventions
Infectious disease policy
Virology
Medicines
Disease control
Disease and Health Conditions
Herpesviruses
Tuberculosis
Country
Bangladesh
Indonesia
Latvia
Tanzania
Bhutan
India
Malaysia
United Kingdom
Sri Lanka
Pakistan
Region
East Asia & Pacific (all income levels)
Sub-Saharan Africa (all income levels)
European Union
South Asia

Selected Publications

Impact of active case finding for tuberculosis with mass chest X-ray screening in Glasgow, Scotland, 1950-1963: An epidemiological analysis of historical data.
MacPherson, P; STAGG, HR; SCHWALB, A; Henderson, H; Taylor, AE; BURKE, RM; RICKMAN, HM; Miller, C; HOUBEN, RM G J; Dodd, PJ; CORBETT, EL;
2024
PLoS medicine
Summary of posterior draws from pulmonary tuberculosis model
MacPherson, P; STAGG, HR; SCHWALB, A; Henderson, H; Taylor, AE; BURKE, RM; RICKMAN, HM; Miller, C; HOUBEN, RM G J; Dodd, PJ; CORBETT, EL;
2024
PLOS Medicine
Development and description of a theory-driven, evidence-based, complex intervention to improve adherence to treatment for tuberculosis in the UK: the IMPACT study
Jones, AS K; Horne, R; White, J; Costello, T; Darvell, M; Karat, AS; Kielmann, K; STAGG, HR; Hill, AT; Kunst, H; Campbell, CN J; Lipman, MC I;
2023
Health Psychology and Behavioral Medicine
No action is without its side effects: Adverse drug reactions and missed doses of antituberculosis therapy, a scoping review.
Dixon, EG; Rasool, S; Otaalo, B; Motee, A; Dear, JW; Sloan, D; STAGG, HR;
2023
British journal of clinical pharmacology
The use of digital technologies in adherence to anti-tuberculosis treatment.
FIELDING, K; Subbaraman, R; Khan, A; Celan, C; Charalambous, S; Franke, MF; Huddart, S; Katamba, A; Law, S; STAGG, H;
2023
Digital Respiratory Healthcare
Recent advances in the treatment of tuberculosis.
Motta, I; Boeree, M; Chesov, D; DHEDA, K; Günther, G; Horsburgh, CR; Kherabi, Y; Lange, C; Lienhardt, C; McIlleron, HM; PATON, NI; STAGG, HR; Thwaites, G; Udwadia, Z; Van Crevel, R; Velásquez, GE; Wilkinson, RJ; Guglielmetti, L; Study group on Mycobacteria (ESGMYC) of the Europe,;
2023
Clinical Microbiology and Infection
Students' and staffs' views and experiences of asymptomatic testing on a university campus during the COVID-19 pandemic in Scotland: a mixed methods study.
Bauld, L; Street, A; Connelly, R; Bevan, I; Morlet Corti, Y; Baxter, MS; STAGG, HR; Christison, S; Mulherin, T; Sinclair, L; Aitman, T;
2023
BMJ open
Mendelian randomisation identifies priority groups for prophylactic EBV vaccination.
Muckian, MD; Wilson, JF; Taylor, GS; STAGG, HR; Pirastu, N;
2023
BMC infectious diseases
The cascade of care for latent tuberculosis infection in congregate settings: A national cohort analysis, Korea, 2017-2018.
Min, J; Kim, HW; STAGG, HR; Rangaka, MX; Lipman, M; Abubakar, I; Lee, Y; Myong, J-P; Jeong, H; Bae, S; Shin, AY; Kang, JY; Lee, S-S; Park, JS; Yim, HW; Kim, JS;
2022
Frontiers in Medicine
See more information